Page last updated: 2024-11-05

divinyl sulfone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

divinyl sulfone: cross-linking reagent for agarose gels [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

divinyl sulfone : A sulfone compound having two S-vinyl substituents. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6496
CHEMBL ID349205
CHEBI ID53729
SCHEMBL ID23101
MeSH IDM0054946

Synonyms (70)

Synonym
nsc133793
nsc-133793
1,1'-sulphonylbisethene
divinyl sulphone
nsc-57304
nsc57304
ethene,1'-sulfonylbis-
vinyl sulfone
tl 797
divinyl sulfone
nsc18590
nsc-18590
sulfone, divinyl-
bis(ethenyl)sulfone
wln: 1u1sw1u1
77-77-0
ethene, 1,1'-sulfonylbis-
1,1'-sulfonyldiethylene
inchi=1/c4h6o2s/c1-3-7(5,6)4-2/h3-4h,1-2h
ai3-26598
nsc 18590
brn 1071329
ccris 4349
hsdb 2028
einecs 201-057-6
divinyl sulfone, contains <650 ppm hydroquinone as inhibitor, 97%
D0959
1-ethenylsulfonylethene
CHEMBL349205
1-(vinylsulfonyl)ethylene
CHEBI:53729 ,
(ch2=ch)2so2
1,1'-sulfonyldiethene
ethenesulfonyl-ethene
vinyl sulphone
A23558
1,3,2-dioxaphospholane, 2-chloro-;1,3,2-dioxaphosphorane.2-chloro-;ethylenephosphorochloridite
AKOS009156703
unii-5pfn71lp8m
5pfn71lp8m ,
divinylsulfone
diethenyl sulphone
(ethenylsulfonyl)ethene
STL373436
EPITOPE ID:116218
ethene,1,1'-sulfonylbis-
BBL027719
SCHEMBL23101
ethenylsulfonylethene
1-vinylsulfonylethylene
vinylsulfonylethene
vinyl sulfone [hsdb]
vinylsulfone
(vinylsulfonyl)ethene
1-(vinylsulfonyl)ethylene #
(ethenesulfonyl)ethene
STR02154
F8889-6525
DTXSID6031253
mfcd00008623
divinyl sulfone, 97%, stab. with 0.05% hydroquinone
J-802197
methyl 2-isothiocyanato propionate
divinyl sulfone, purum, >=98.0% (gc)
divinyl sulfone, stabilized with hq
AT13126
Q27104812
62804-37-9
EN300-36195
Z362768182

Research Excerpts

Overview

Divinyl sulfone (DVS) is an important oxidative metabolic product of sulfur mustard (SM) in vitro and in vivo.

ExcerptReferenceRelevance
"Divinyl sulfone (DVS) is an important oxidative metabolic product of sulfur mustard (SM) in vitro and in vivo. "( Synthesis, Characterization, and Identification of New in Vitro Covalent DNA Adducts of Divinyl Sulfone, an Oxidative Metabolite of Sulfur Mustard.
Chen, J; Gao, Z; Lv, S; Wu, J; Xie, J; Xu, B; Xu, H; Zhang, Y; Zhao, Y, 2017
)
2.12

Toxicity

ExcerptReferenceRelevance
"Previously, we determined that diethyl acetylenedicarboxylate (DAD), a protein cross-linker, was significantly more toxic than analogous monofunctional electrophiles."( Enhanced toxicity of the protein cross-linkers divinyl sulfone and diethyl acetylenedicarboxylate in comparison to related monofunctional electrophiles.
Brown, HA; Justice, SL; Morano, KA; Stamm, CE; West, JD, 2011
)
0.63

Bioavailability

ExcerptReferenceRelevance
" These ligands were further studied for molecular docking with Nrf2-keap protein to gain insight into the major binding motifs followed by analysing pharmacokinetic properties to evaluate their bioavailability dominance."( Pharmacophore model prediction, 3D-QSAR and molecular docking studies on vinyl sulfones targeting Nrf2-mediated gene transcription intended for anti-Parkinson drug design.
Athar, M; Jha, PC; Khedkar, VM; Lone, MY, 2016
)
0.43
" Such side-reactions are not desirable for any drug candidate since they limit serum stability, bioavailability and they possibly trigger toxicity mechanisms."( Serum albumin as a probe for testing the selectivity of irreversible cysteine protease inhibitors: The case of vinyl sulfones.
Carini, M; Colombo, S; Mazzolari, A; Regazzoni, L; Vistoli, G, 2016
)
0.43

Dosage Studied

ExcerptRelevanceReference
" The HA - exendin 4 conjugates will be investigated further as a twice a week injection dosage form for clinical applications."( Long acting hyaluronate--exendin 4 conjugate for the treatment of type 2 diabetes.
Chae, SY; Hahn, SK; Kong, JH; Lee, KC; Oh, EJ, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
cross-linking reagentA reagent with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between macromolecules, principally side chains of amino acids in proteins, allowing the locations of naturally reactive areas within the proteins to be identified.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
sulfoneAn organosulfur compound having the structure RS(=O)2R (R =/= H).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID89966In vitro inhibition of inducible vascular cell adhesion molecule-1 (VCAM-1) expression in Human aortic endothelial cells (HAEC)2003Bioorganic & medicinal chemistry letters, Feb-24, Volume: 13, Issue:4
Lead discovery of alpha,beta-unsaturated sulfones from a combinatorial library as inhibitors of inducible VCAM-1 expression.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (244)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (2.87)18.7374
1990's20 (8.20)18.2507
2000's68 (27.87)29.6817
2010's104 (42.62)24.3611
2020's45 (18.44)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.90 (24.57)
Research Supply Index5.54 (2.92)
Research Growth Index5.19 (4.65)
Search Engine Demand Index50.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews9 (3.56%)6.00%
Case Studies1 (0.40%)4.05%
Observational0 (0.00%)0.25%
Other243 (96.05%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]